Interstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab. Beuerlein KG, Martin ED, Strowd LC. Cutis 2022;109:167-169.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Beuerlein KG, Martin ED, Strowd LC. Interstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab. Cutis 2022;109:167-169.
PMID: 35659138